Sangamo Therapeutics Inc. (SGMO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sangamo Therapeutics Inc.

    NASDAQ: SGMO · Real-Time Price · USD
    0.55
    0.02 (3.73%)
    At close: Sep 05, 2025, 3:59 PM
    0.54
    -1.32%
    After-hours: Sep 05, 2025, 07:52 PM EDT

    Sangamo Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 57.8M 176.23M 111.3M 110.7M
    Cost of Revenue
    		 9.36M 22.19M 12.11M 9.44M
    Gross Profit
    		 57.8M 154.04M 99.19M 101.26M
    Operating Income
    		 -103.97M -274M -201.28M -183.34M
    Interest Income
    		 5.86M 11.1M 9.43M 5.35M
    Pretax Income
    		 -98.11M -262.9M -191.85M -177.99M
    Net Income
    		 -97.94M -257.83M -192.28M -178.3M
    Selling & General & Admin
    		 44.73M 61.17M 62.68M 63.22M
    Research & Development
    		 111.52M 234.06M 249.9M 230.82M
    Other Expenses
    		 5.52M -66.54M -12.11M -9.44M
    Operating Expenses
    		 161.77M 228.68M 300.47M 284.6M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 156.93M 450.24M 312.58M 294.04M
    Income Tax Expense
    		 -167K -5.07M 429K 306K
    Shares Outstanding (Basic)
    		 201.7M 174.44M 154.34M 144.57M
    Shares Outstanding (Diluted)
    		 201.7M 174.44M 154.34M 144.57M
    EPS (Basic)
    		 -0.49 -1.48 -1.25 -1.23
    EPS (Diluted)
    		 -0.49 -1.48 -1.25 -1.23
    EBITDA
    		 -89.09M -240.71M -189.17M -173.9M
    EBIT
    		 -98.45M -102.49M -201.28M -183.34M
    Depreciation & Amortization
    		 9.36M 22.19M 12.11M 9.44M

    Add to Watchlist